10 mg Peptide Strength
Each vial contains a labeled strength of 10 mg of survodutide.
Dragon Pharma
You will save $40.00
Survodutide 10 mg
GLP-1/Glucagon Receptor Agonist Peptide
- Product: Survodutide 10 mg
- Active Substance: Survodutide
- Strength: 10 mg/vial
- Container: 2 mL vial
- Manufacturer: Dragon Pharma
$60.00
$100.00
Warehouse :
International
U.S. Domestic
Dragon Pharma Peptide Product
Dragon Pharma Survodutide 10 mg Overview
Dragon Pharma Survodutide is supplied as a lyophilized powder in a 2 mL vial and contains the dual GLP-1/glucagon receptor agonist survodutide at a labeled strength of 10 mg. Product specifications, a batch-specific lab report, storage information, and available payment options are provided below.
Lyophilized Powder Form
Supplied as a freeze-dried powder that requires reconstitution with bacteriostatic water before use.
2 mL Vial
Packaged in a standard 2 mL peptide vial with a rubber stopper and aluminum seal.
Published Lab Report
A published lab report from September 2024 provides measured results for the identified batch.
Product Specifications
| Product name | Survodutide 10 mg |
|---|---|
| Active substance | Survodutide |
| Labeled strength | 10 mg/vial |
| Container | 2 mL vial |
| Total labeled content | 10 mg per vial |
| Product form | Lyophilized powder |
| Manufacturer | Dragon Pharma |
Latest Lab Result
The latest published report for batch #SVDHD7, dated September 13, 2024, measured 9.68 mg against the stated 10 mg labeled strength.
Open the Lab Reports tab to view the full report and check the batch number associated with the test.
Related Peptide Options
Other peptide options from the same product line include Retatrutide 10 mg, a triple agonist peptide, and Mazdutide 10 mg, another dual GLP-1/glucagon receptor agonist. These products differ in their receptor targets and research applications.
Published Test Result
Dragon Pharma Survodutide 10 mg Lab Report
A published lab report for Dragon Pharma Survodutide 10 mg is provided below with the test date, measured result and reported batch number. The result can be compared directly with the product's labeled strength of 10 mg.
Published Report
September 13, 2024 Laboratory Test
- Label claim
- 10 mg
- Measured result
- 9.68 mg
- Measured vs. label
- 96.80%
- Batch
- #SVDHD7
- Test date
Science & Research
Understanding Survodutide
Survodutide is a synthetic peptide that acts as a dual agonist at the glucagon-like peptide-1 (GLP-1) and glucagon receptors. This section provides a brief overview of what is known about this peptide from research literature.
Dual Receptor Agonist
Survodutide is a dual agonist peptide that activates both GLP-1 and glucagon receptors. This combined mechanism distinguishes it from peptides that target only a single receptor.
Metabolic Research
Preclinical research has investigated survodutide for its potential effects on metabolic processes through its actions at both GLP-1 and glucagon receptor pathways.
Research Applications
Dual agonist peptides such as survodutide have been studied in research settings for their interactions with metabolic pathways. The peptide has been investigated for its potential effects on energy balance and related physiological processes.
Peptide Reconstitution and Use
This product is supplied as a lyophilized powder and must be reconstituted with bacteriostatic water or sterile water for injection before use. The addition of water converts the freeze-dried powder into a solution suitable for research applications.
The reconstituted peptide solution should be stored as recommended on the product label. Peptide solutions are typically refrigerated and used within a specified timeframe after reconstitution to maintain integrity.
Research References
Peer-reviewed research on survodutide is available through the National Institutes of Health and other scientific databases. The following link provides general information on this peptide and its mechanism of action.
Important Health Information
Survodutide 10 mg Safety Information
Peptide research compounds such as survodutide have limited clinical safety data. The information below is derived from published preclinical research and general knowledge of incretin biology and does not constitute medical advice.
Limited Clinical Data
Survodutide has not been extensively studied in humans outside of clinical research settings. The available safety information comes primarily from preclinical research.
Metabolic Effects
Peptides that activate GLP-1 and glucagon receptors may affect glucose metabolism, insulin sensitivity and energy balance. The significance of dual agonism is not fully characterized for survodutide.
Injection-Related Risks
Subcutaneous injection carries risks including injection-site reactions, infection and improper technique. Sterile handling and correct reconstitution procedures are essential.
Hormonal Interactions
Compounds that affect incretin pathways may interact with other hormonal systems. The potential significance of these interactions is not fully understood.
Contraindications
This peptide research compound should not be used by individuals with known allergies or sensitivities to peptide compounds, or by those who are pregnant, nursing or have active malignancies.
Limited Research
The long-term effects and safety profile of survodutide have not been established in any population. Research on this peptide is still in the early stages.
Conditions That Require Medical Review
Medical advice is particularly important for individuals with diabetes or glucose metabolism disorders, cardiovascular disease, cancer or a history of cancer, gastrointestinal conditions, or those taking medications that affect blood sugar. This peptide should not be used during pregnancy or breastfeeding.
The product should also be stored securely to prevent accidental access or use by children or other household members, particularly after reconstitution when it contains a liquid solution.
Tested Sport
Survodutide is not specifically listed on the World Anti-Doping Agency Prohibited List at the time of writing. Athletes should check the current list before competition, as prohibited substances are subject to change. Some peptide compounds may fall under general prohibitions on substances with similar biological effects.
The current status and applicable rules can be checked through the World Anti-Doping Agency Prohibited List.
Common Product Questions
Dragon Pharma Survodutide 10 mg FAQ
Quick answers about Survodutide 10 mg specifications, the published lab report, storage, shipping, Bitcoin payment and general product information.
What is Dragon Pharma Survodutide 10 mg?
Dragon Pharma Survodutide 10 mg is a lyophilized peptide product containing 10 mg of the dual GLP-1/glucagon receptor agonist survodutide per vial. It is supplied in a 2 mL vial for research purposes.
What is survodutide?
Survodutide is a synthetic peptide that acts as a dual agonist at the GLP-1 and glucagon receptors. It has been investigated in preclinical research for its potential effects on metabolic processes.
How much peptide is in each vial?
Each vial contains a labeled strength of 10 mg of survodutide.
How is the product supplied?
The product is supplied as a lyophilized powder in a 2 mL vial. It requires reconstitution with bacteriostatic water or sterile water for injection before use.
What did the lab report show for this product?
The published lab report dated September 13, 2024 for batch #SVDHD7 measured 9.68 mg against the stated 10 mg labeled strength.
Does the lab report verify every vial?
No. Each report applies to the sample submitted for that specific test and the batch identified in the report. It does not independently verify the content or condition of every individual vial.
How should Survodutide be stored?
Store the lyophilized powder in its original packaging at room temperature or refrigerated, protected from excessive heat, moisture and direct light. Once reconstituted, peptide solutions typically require refrigeration and should be used within a limited timeframe. Always follow the specific storage directions printed on the product label.
Does Survodutide require refrigeration?
Lyophilized peptide powders are generally stable at room temperature but should be protected from heat. After reconstitution, peptide solutions typically require refrigeration. Check the product label for specific storage instructions.
How long does Survodutide delivery take?
Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.
Can I buy Survodutide with Bitcoin?
Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy Survodutide 10 mg with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.
Is Bitcoin payment anonymous?
Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.
Is Survodutide permitted in tested sport?
Survodutide is not specifically listed on the World Anti-Doping Agency Prohibited List at the time of writing. Athletes should check the current list before competition, as prohibited substances are subject to change.
Where can I find more information on Survodutide?
Additional research on this peptide is available through the National Institutes of Health and other scientific databases. A direct link to PubMed references is provided in the Science & Research section above.
No reviews found
Please log in to write Survodutide 10 mg review.
Related Offers
Lab Tested
Domestic & International
-40% OFF
Dragon Pharma, Europe
Incretin-Based Peptide (GLP-1/Glucagon Receptor Research)
- Product: Mazdutide 10 mg
- Active Substance: Mazdutide
- Strength: 10 mg/vial
- Container: 2 mL vial
- Manufacturer: Dragon Pharma
$60.00
$100.00
Domestic & International
-40% OFF
Dragon Pharma, Europe
Melanocortin Peptide (Sexual Function Research Compound)
- Product: PT-141 10 mg
- Active Substance: Bremelanotide
- Strength: 10 mg/vial
- Container: 2 mL vial
- Manufacturer: Dragon Pharma
$27.00
$45.00
Domestic & International
-40% OFF
Dragon Pharma, Europe
Growth Hormone Secretagogue
- Product: Sermorelin 5 mg
- Active Substance: Sermorelin
- Strength: 5 mg/vial
- Container: 2 mL vial
- Manufacturer: Dragon Pharma
$27.00
$45.00
Lab Tested
Domestic & International
-40% OFF
Dragon Pharma, Europe
Long-Acting Amylin Analog (Research Peptide)
- Product: Cagrilintide 10 mg
- Active Substance: Cagrilintide Acetate
- Strength: 10 mg/vial
- Container: 2 mL vial
- Manufacturer: Dragon Pharma
$60.00
$100.00